A lthough we regret that Liu and coworkers were not able to cultivate Pneumocystis jirovecii in our cell culture model proposed 4 years ago (1), we appreciate their comments, as they exactly reflect the problems with which we were dealing. While we presented those attempts that were successful, there were also BAL specimens with proven high mitochondrial large-subunit (mtLSU) rRNA that failed, a fact for which we had no explanation at that time. In our paper, we suggested that quantification based on the established methods may be misleading with regard to the amount of pathogenic particles, and in addition, there are indications that there are differences in P. jirovecii "positivity" concerning life cycle or metabolic stages (2; C. M. Dunaiski et al., submitted); we do not know how they react under culturing conditions. For this reason, 10 BAL specimens is a limited number to establish and check the system, especially as one has to take into account that the CuFi-8 model in its presented form is not yet appropriate for routine culturing. Our published culture system was a prototype. We have tried to acquire funding from both national and international sources to optimize this culture system but were unable to obtain funding to refine and simplify the model developed in 2014.
